<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">
    ss
   </journal-id>
   <journal-title-group>
    <journal-title>
     Surgical Science
    </journal-title>
   </journal-title-group>
   <issn pub-type="epub">
    2157-9407
   </issn>
   <issn publication-format="print">
    2157-9415
   </issn>
   <publisher>
    <publisher-name>
     Scientific Research Publishing
    </publisher-name>
   </publisher>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="doi">
    10.4236/ss.2025.161003
   </article-id>
   <article-id pub-id-type="publisher-id">
    ss-139945
   </article-id>
   <article-categories>
    <subj-group subj-group-type="heading">
     <subject>
      Articles
     </subject>
    </subj-group>
    <subj-group subj-group-type="Discipline-v2">
     <subject>
      Medicine 
     </subject>
     <subject>
       Healthcare
     </subject>
    </subj-group>
   </article-categories>
   <title-group>
    The Cause of Hirschsprung’s Disease in Bardet Biedl Syndrome in Children 
   </title-group>
   <contrib-group>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Naga Venkata Chakra Satyanarayana
      </surname>
      <given-names>
       Amarthi
      </given-names>
     </name>
    </contrib>
    <contrib contrib-type="author" xlink:type="simple">
     <name name-style="western">
      <surname>
       Terry
      </surname>
      <given-names>
       Oroszi
      </given-names>
     </name>
    </contrib>
   </contrib-group> 
   <aff id="affnull">
    <addr-line>
     aDepartment of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio, USA
    </addr-line> 
   </aff> 
   <pub-date pub-type="epub">
    <day>
     14
    </day> 
    <month>
     01
    </month>
    <year>
     2025
    </year>
   </pub-date> 
   <volume>
    16
   </volume> 
   <issue>
    01
   </issue>
   <fpage>
    15
   </fpage>
   <lpage>
    25
   </lpage>
   <history>
    <date date-type="received">
     <day>
      30,
     </day>
     <month>
      March
     </month>
     <year>
      2024
     </year>
    </date>
    <date date-type="published">
     <day>
      13,
     </day>
     <month>
      March
     </month>
     <year>
      2024
     </year> 
    </date> 
    <date date-type="accepted">
     <day>
      13,
     </day>
     <month>
      January
     </month>
     <year>
      2025
     </year> 
    </date>
   </history>
   <permissions>
    <copyright-statement>
     © Copyright 2014 by authors and Scientific Research Publishing Inc. 
    </copyright-statement>
    <copyright-year>
     2014
    </copyright-year>
    <license>
     <license-p>
      This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/
     </license-p>
    </license>
   </permissions>
   <abstract>
    Hirschsprung’s disease (HSCR) is a developmental disorder characterized by the absence of ganglion cells in the distal colon, leading to functional obstruction. Bardet-Biedl syndrome (BBS) is a rare ciliopathy associated with various clinical features, including HSCR. This review article aims to explore the underlying causes of HSCR in children with BBS, focusing on the genetic and developmental factors contributing to the pathogenesis of both conditions. We reviewed relevant literature, including peer-reviewed journal articles and case reports, to provide a comprehensive overview of the current understanding of the relationship between HSCR and BBS. Our findings highlight the complex interplay of genetic mutations, signaling pathways, and developmental processes involved in the pathogenesis of HSCR in BBS. Further research is needed to elucidate the precise mechanisms underlying this association and to develop targeted therapeutic strategies for children with HSCR and BBS. 
   </abstract>
   <kwd-group> 
    <kwd>
     Hirschsprung’s Disease
    </kwd> 
    <kwd>
      Bardet-Biedl Syndrome
    </kwd> 
    <kwd>
      Ciliopathy
    </kwd> 
    <kwd>
      Genetics
    </kwd> 
    <kwd>
      Developmental Disorder
    </kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <sec id="s1">
   <title>1. Introduction</title>
   <p>Hirschsprung’s disease (HSCR) is a congenital disorder characterized by the absence of ganglion cells in the distal colon, leading to functional intestinal obstruction <xref ref-type="bibr" rid="scirp.139945-1">
     [1]
    </xref> <xref ref-type="bibr" rid="scirp.139945-2">
     [2]
    </xref>. While HSCR is often an isolated condition, it can also be associated with various chromosomal abnormalities, congenital anomalies, and syndromes, including Bardet-Biedl syndrome (BBS) <xref ref-type="bibr" rid="scirp.139945-3">
     [3]
    </xref>. BBS is a rare, multisystemic ciliopathy with diverse clinical features, such as obesity, retinal dystrophy, polydactyly, renal abnormalities, and developmental delays <xref ref-type="bibr" rid="scirp.139945-4">
     [4]
    </xref>.</p>
   <p>The association between HSCR and BBS has been documented in several studies, suggesting a potential link between these two seemingly distinct conditions. Day, Avila, and Novak <xref ref-type="bibr" rid="scirp.139945-5">
     [5]
    </xref> reported two cases of HSCR in siblings with BBS, highlighting the challenges in diagnosis and management. Their study underscores the importance of recognizing the potential for HSCR in children with BBS and emphasizes the need for further research to elucidate the underlying mechanisms connecting these complex disorders <xref ref-type="bibr" rid="scirp.139945-6">
     [6]
    </xref>.</p>
   <p>This review article aims to explore the current understanding of the relationship between HSCR and BBS, focusing on the genetic, developmental, and clinical aspects of these conditions. We will examine the prevalence, pathogenesis, clinical presentation, and management of HSCR in children with BBS, drawing upon the latest research findings and clinical experience. Additionally, we will discuss the potential implications of this association for future research and clinical practice.</p>
  </sec><sec id="s2">
   <title>2. Bardet-Biedl Syndrome: An Overview</title>
   <p>Bardet-Biedl syndrome (BBS) is a rare, autosomal recessive disorder characterized by a wide range of clinical features <xref ref-type="bibr" rid="scirp.139945-7">
     [7]
    </xref>-<xref ref-type="bibr" rid="scirp.139945-10">
     [10]
    </xref>. As a ciliopathy, BBS arises from dysfunction of primary cilia, which are microtubule-based organelles involved in cellular signaling and sensory perception <xref ref-type="bibr" rid="scirp.139945-11">
     [11]
    </xref> <xref ref-type="bibr" rid="scirp.139945-12">
     [12]
    </xref>. This dysfunction affects multiple organ systems, leading to the diverse manifestations of the syndrome <xref ref-type="bibr" rid="scirp.139945-13">
     [13]
    </xref>.</p>
   <sec id="s2_1">
    <title>2.1. Genetic Basis</title>
    <p>BBS is genetically heterogeneous, with mutations identified in over 20 genes, including BBS1, BBS2, ARL6, BBS4, BBS5, and others <xref ref-type="bibr" rid="scirp.139945-14">
      [14]
     </xref> <xref ref-type="bibr" rid="scirp.139945-15">
      [15]
     </xref>. While a direct correlation between specific mutations and disease severity remains elusive, some trends have been observed. For instance, certain mutations in the BBS1 gene appear to be associated with milder ophthalmologic involvement <xref ref-type="bibr" rid="scirp.139945-16">
      [16]
     </xref>. Conversely, mutations in BBS10 may predispose individuals to obesity and insulin resistance <xref ref-type="bibr" rid="scirp.139945-17">
      [17]
     </xref>.</p>
   </sec>
   <sec id="s2_2">
    <title>2.2. Clinical Features</title>
    <p>The clinical spectrum of BBS is broad, encompassing both major and minor features. Major features are those that occur with higher frequency and are often considered cardinal manifestations of the syndrome. Minor features, while less prevalent, contribute to the overall clinical picture and can significantly impact patient management. See <xref ref-type="table" rid="table1">
      Table 1
     </xref> to see the diverse clinical features and their approximate frequencies.</p>
   </sec>
   <sec id="s2_3">
    <title>2.3. Caring for Children with Bardet-Biedl Syndrome</title>
    <p>Bardet-Biedl syndrome (BBS) presents unique challenges for affected children and their families. Given the rarity and complexity of this multisystem disorder, parents often feel unprepared to navigate the associated medical, developmental, and psychosocial issues <xref ref-type="bibr" rid="scirp.139945-18">
      [18]
     </xref>. Therefore, healthcare professionals play a crucial role in providing comprehensive support and guidance.</p>
    <table-wrap id="table1">
     <label>
      <xref ref-type="table" rid="table1">
       Table 1
      </xref></label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.139945-"></xref>Table 1. Bardet-Biedl Syndrome features, frequency, and foundation.</title>
     </caption>
     <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
      <tr> 
       <td class="custom-bottom-td aleft" width="8.28%"><p style="text-align:left">Feature Category</p></td> 
       <td class="custom-bottom-td aleft" width="19.17%"><p style="text-align:left">Specific Feature</p></td> 
       <td class="custom-bottom-td aleft" width="11.04%"><p style="text-align:left">Approximate Frequency</p></td> 
       <td class="custom-bottom-td aleft" width="61.51%"><p style="text-align:left">Clinical Significance</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td aleft" width="8.28%"><p style="text-align:left">Major Features</p></td> 
       <td class="custom-top-td aleft" width="19.17%"><p style="text-align:left">Retinal cone-rod dystrophy</p></td> 
       <td class="custom-top-td aleft" width="11.04%"><p style="text-align:left">94%</p></td> 
       <td class="custom-top-td aleft" width="61.51%"><p style="text-align:left">Progressive vision loss, often leading to legal blindness. Requires regular ophthalmological monitoring and management <xref ref-type="bibr" rid="scirp.139945-19">
          [19]
         </xref> <xref ref-type="bibr" rid="scirp.139945-20">
          [20]
         </xref>.</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="8.28%"><p style="text-align:left"></p></td> 
       <td class="aleft" width="19.17%"><p style="text-align:left">Postaxial polydactyly</p></td> 
       <td class="aleft" width="11.04%"><p style="text-align:left">79%</p></td> 
       <td class="aleft" width="61.51%"><p style="text-align:left">Extra digits on the hands or feet. May require surgical intervention for functional or cosmetic reasons <xref ref-type="bibr" rid="scirp.139945-19">
          [19]
         </xref> <xref ref-type="bibr" rid="scirp.139945-21">
          [21]
         </xref>.</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="8.28%"><p style="text-align:left"></p></td> 
       <td class="aleft" width="19.17%"><p style="text-align:left">Central obesity</p></td> 
       <td class="aleft" width="11.04%"><p style="text-align:left">89%</p></td> 
       <td class="aleft" width="61.51%"><p style="text-align:left">Significant weight gain, typically beginning in childhood. Contributes to metabolic complications and requires dietary and lifestyle interventions <xref ref-type="bibr" rid="scirp.139945-19">
          [19]
         </xref> <xref ref-type="bibr" rid="scirp.139945-22">
          [22]
         </xref>.</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="8.28%"><p style="text-align:left">Minor Features</p></td> 
       <td class="aleft" width="19.17%"><p style="text-align:left">Gastrointestinal abnormalities (including HSCR)</p></td> 
       <td class="aleft" width="11.04%"><p style="text-align:left">2.80%</p></td> 
       <td class="aleft" width="61.51%"><p style="text-align:left">Hirschsprung’s disease, along with other gastrointestinal issues, can cause significant morbidity. Requires specialized care and may necessitate surgical treatment <xref ref-type="bibr" rid="scirp.139945-19">
          [19]
         </xref>.</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="8.28%"><p style="text-align:left"></p></td> 
       <td class="aleft" width="19.17%"><p style="text-align:left">Genitourinary abnormalities</p></td> 
       <td class="aleft" width="11.04%"><p style="text-align:left">Variable</p></td> 
       <td class="aleft" width="61.51%"><p style="text-align:left">Structural or functional abnormalities of the kidneys and urinary tract. Can lead to renal insufficiency and require nephrological management <xref ref-type="bibr" rid="scirp.139945-19">
          [19]
         </xref>.</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="8.28%"><p style="text-align:left"></p></td> 
       <td class="aleft" width="19.17%"><p style="text-align:left">Endocrine and metabolic abnormalities</p></td> 
       <td class="aleft" width="11.04%"><p style="text-align:left">Variable</p></td> 
       <td class="aleft" width="61.51%"><p style="text-align:left">Includes diabetes mellitus type 2 (15.8%), hypothyroidism (19.4%), and metabolic syndrome (54%). Requires careful monitoring and management to prevent long-term complications <xref ref-type="bibr" rid="scirp.139945-19">
          [19]
         </xref>.</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="8.28%"><p style="text-align:left"></p></td> 
       <td class="aleft" width="19.17%"><p style="text-align:left">Developmental delay</p></td> 
       <td class="aleft" width="11.04%"><p style="text-align:left">Variable</p></td> 
       <td class="aleft" width="61.51%"><p style="text-align:left">Cognitive impairment and learning difficulties. Requires educational support and intervention <xref ref-type="bibr" rid="scirp.139945-19">
          [19]
         </xref>.</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="8.28%"><p style="text-align:left"></p></td> 
       <td class="aleft" width="19.17%"><p style="text-align:left">Speech delay</p></td> 
       <td class="aleft" width="11.04%"><p style="text-align:left">Variable</p></td> 
       <td class="aleft" width="61.51%"><p style="text-align:left">Delayed acquisition of language skills. May benefit from speech therapy <xref ref-type="bibr" rid="scirp.139945-19">
          [19]
         </xref>.</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="8.28%"><p style="text-align:left"></p></td> 
       <td class="aleft" width="19.17%"><p style="text-align:left">Behavioral and psychiatric abnormalities</p></td> 
       <td class="aleft" width="11.04%"><p style="text-align:left">Variable</p></td> 
       <td class="aleft" width="61.51%"><p style="text-align:left">Includes anxiety, depression, and autism spectrum disorder. Requires psychological assessment and support <xref ref-type="bibr" rid="scirp.139945-19">
          [19]
         </xref>.</p></td> 
      </tr> 
     </table>
    </table-wrap>
    <p>Note: The frequencies presented in this table are approximate and may vary across different studies and populations.</p>
    <p>Effective care for children with BBS requires a multidisciplinary approach, involving collaboration amongst various specialists, including geneticists, ophthalmologists, endocrinologists, nephrologists, and developmental pediatricians <xref ref-type="bibr" rid="scirp.139945-23">
      [23]
     </xref>. Early diagnosis and intervention are essential to optimize outcomes and improve quality of life.</p>
   </sec>
   <sec id="s2_4">
    <title>2.4. Supporting Families</title>
   </sec>
  </sec><sec id="s3">
   <title>3. Hirschsprung’s Disease: An Overview</title>
   <p>The aganglionic segment in Hirschsprung’s disease (HSCR) can vary in length, typically affecting the rectum and sigmoid colon in short-segment HSCR <xref ref-type="bibr" rid="scirp.139945-1">
     [1]
    </xref>. In some cases, it may extend further to involve longer sections of the colon (long-segment HSCR) or even the entire colon and small intestine, known as total colonic aganglionosis <xref ref-type="bibr" rid="scirp.139945-26">
     [26]
    </xref>.</p>
   <sec id="s3_1">
    <title>3.1. Clinical Presentation</title>
   </sec>
   <sec id="s3_2">
    <title>3.2. Genetic and Environmental Factors</title>
   </sec>
   <sec id="s3_3">
    <title>3.3. The Link between Hirschsprung’s Disease and Bardet-Biedl Syndrome</title>
    <p>Hirschsprung’s disease (HSCR) and Bardet-Biedl syndrome (BBS) are seemingly distinct genetic disorders. HSCR affects the development of the enteric nervous system, leading to intestinal obstruction, while BBS is a multisystem ciliopathy with a wide range of clinical manifestations, including obesity, retinopathy, polydactyly, and renal dysfunction. However, a growing body of evidence suggests a potential link between these two conditions.</p>
   </sec>
   <sec id="s3_4">
    <title>3.4. Genetic Interaction between BBS and HSCR</title>
    <p>Studies have identified mutations in BBS genes among patients diagnosed with both BBS and HSCR, suggesting a possible genetic interaction. Zhang et al. <xref ref-type="bibr" rid="scirp.139945-30">
      [30]
     </xref> investigated two families with both conditions. In one family of Caucasian origin (F1), three siblings affected by a short-segment HSCR harbored two heterozygous missense mutations in a BBS gene. In another family of Moroccan origin (F2), two out of five siblings with BBS also had confirmed HSCR, with all five siblings exhibiting a homozygous 1-bp deletion in the BBS4 gene. Additionally, a sporadic case (SB25) was identified with an infant born to healthy parents of Caucasian origin presenting with both HSCR and BBS, who inherited a heterozygous missense BBS4 mutation from their father <xref ref-type="bibr" rid="scirp.139945-31">
      [31]
     </xref>.</p>
    <p>Further analysis revealed that patients with BBS and HSCR are often carriers of the RET allele, a gene known to be associated with HSCR. Kuil <xref ref-type="bibr" rid="scirp.139945-32">
      [32]
     </xref> suggests sequencing patients for RET mutations to identify potential BBS and HSCR links. In the F1 family, all three affected siblings were homozygous for the intronic hypomorphic T allele of RET, while in the F2 family, only the two siblings with both BBS and HSCR were homozygous for this allele. This suggests that epistasis, or gene-gene interaction, between RET and BBS mutations, may contribute to the development of HSCR.</p>
   </sec>
   <sec id="s3_5">
    <title>3.5. BBS and HSCR: Shared Molecular Pathways</title>
    <p>BBS is a genetically heterogeneous disorder with at least 12 loci and 10 genes identified <xref ref-type="bibr" rid="scirp.139945-24">
      [24]
     </xref>. It is characterized by defects in primary cilia, which play critical roles in various cellular processes, including signal transduction and development. Interestingly, recent research has implicated cilia dysfunction in the pathogenesis of HSCR. This raises the possibility that shared molecular pathways involving cilia dysfunction may underlie the link between BBS and HSCR.</p>
   </sec>
  </sec><sec id="s4">
   <title>4. Clinical Overlap and Case Reports</title>
   <p>The McKusick-Kaufman syndrome (MKKS) is a rare disorder allelic to BBS, characterized by postaxial polydactyly, congenital heart defects, and, in some cases, HSCR (Alvarez-Satta, Castro-Sanchez and Valverde 2017). The clinical overlap between BBS, MKKS, and HSCR further supports a connection between these conditions. Case reports, such as the one described by Kapor, Smith, and Ambartsumyan <xref ref-type="bibr" rid="scirp.139945-33">
     [33]
    </xref> involving a 3-year-old child with BBS presenting with HSCR, provide additional evidence for this association.</p>
   <sec id="s4_1">
    <title>4.1. Effects of HSCR and BBS in Children</title>
    <p>Both HSCR and BBS can significantly impact a child’s quality of life. HSCR can lead to complications such as intestinal obstruction, constipation, enterocolitis, and potentially life-threatening infections. BBS, with its multisystem involvement, can result in vision loss, obesity, renal dysfunction, developmental delays, and behavioral issues.</p>
   </sec>
   <sec id="s4_2">
    <title>4.2. Prevalence and Clinical Presentation</title>
    <p>The prevalence of BBS varies geographically, ranging from 1 in 140,000 to 1 in 160,000 newborns in North America and Europe <xref ref-type="bibr" rid="scirp.139945-34">
      [34]
     </xref>. HSCR is more common in males and can present with symptoms such as abdominal distention, constipation, and vomiting. Children with BBS may exhibit a range of behavioral issues, including internalizing problems like anxiety and depression <xref ref-type="bibr" rid="scirp.139945-35">
      [35]
     </xref>. <xref ref-type="table" rid="table2">
      Table 2
     </xref> summarizes the key features and overlapping manifestations found in both HSCR and BBS.</p>
    <table-wrap id="table2">
     <label>
      <xref ref-type="table" rid="table2">
       Table 2
      </xref></label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.139945-"></xref>Table 2. Summary of key features and overlapping manifestations of HSCR and BBS.</title>
     </caption>
     <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
      <tr> 
       <td class="custom-bottom-td aleft" width="17.80%"><p style="text-align:left">Feature</p></td> 
       <td class="custom-bottom-td aleft" width="32.27%"><p style="text-align:left">Hirschsprung’s Disease (HSCR)</p></td> 
       <td class="custom-bottom-td aleft" width="25.11%"><p style="text-align:left">Bardet-Biedl Syndrome (BBS)</p></td> 
       <td class="custom-bottom-td aleft" width="24.81%"><p style="text-align:left">Overlapping Manifestations</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td aleft" width="17.80%"><p style="text-align:left">Primary Defect</p></td> 
       <td class="custom-top-td aleft" width="32.27%"><p style="text-align:left">Abnormal development of the enteric nervous system</p></td> 
       <td class="custom-top-td aleft" width="25.11%"><p style="text-align:left">Dysfunction of primary cilia</p></td> 
       <td class="custom-top-td aleft" width="24.81%"><p style="text-align:left">Potentially shared molecular pathways involving cilia dysfunction</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="17.80%"><p style="text-align:left">Genetic Heterogeneity</p></td> 
       <td class="aleft" width="32.27%"><p style="text-align:left">Associated with RET gene and other loci</p></td> 
       <td class="aleft" width="25.11%"><p style="text-align:left">At least 12 loci and 10 genes identified</p></td> 
       <td class="aleft" width="24.81%"><p style="text-align:left">Some BBS genes may interact with RET, increasing HSCR risk</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="17.80%"><p style="text-align:left">Clinical Manifestations</p></td> 
       <td class="aleft" width="32.27%"><p style="text-align:left">Intestinal obstruction, constipation, enterocolitis</p></td> 
       <td class="aleft" width="25.11%"><p style="text-align:left">Obesity, retinopathy, polydactyly, renal dysfunction, developmental delays</p></td> 
       <td class="aleft" width="24.81%"><p style="text-align:left">HSCR observed in some BBS patients, particularly those with MKKS</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="17.80%"><p style="text-align:left">Prevalence</p></td> 
       <td class="aleft" width="32.27%"><p style="text-align:left">More common in males</p></td> 
       <td class="aleft" width="25.11%"><p style="text-align:left">Varies geographically</p></td> 
       <td class="aleft" width="24.81%"><p style="text-align:left"></p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="17.80%"><p style="text-align:left">Treatment</p></td> 
       <td class="aleft" width="32.27%"><p style="text-align:left">Surgical intervention</p></td> 
       <td class="aleft" width="25.11%"><p style="text-align:left">Symptomatic management, supportive care</p></td> 
       <td class="aleft" width="24.81%"><p style="text-align:left"></p></td> 
      </tr> 
     </table>
    </table-wrap>
   </sec>
   <sec id="s4_3">
    <title>4.3. Further Research</title>
    <p>While the link between HSCR and BBS is becoming increasingly evident, further research is needed to fully elucidate the underlying mechanisms. Investigating the role of cilia dysfunction in both conditions, identifying additional genetic interactions, and exploring potential shared signaling pathways may provide valuable insights for diagnosis, treatment, and genetic counseling.</p>
   </sec>
  </sec><sec id="s5">
   <title>5. Counseling</title>
   <p>In interrelationship marriages, individuals should receive counseling on the features, impacts, and effects of their situation, including the genetic implications. Hirschsprung’s disease (HSCR) is a congenital malformation with a 4% overall recurrence risk in the proband’s siblings (relative risk = 200). In isolated HSCR, the sex and aganglionic segment of the proband, as well as the gender of the sibling, provide adequate relative risk estimates. Many instances of HSCR are linked to other genetic abnormalities, and the severity of these associated malformations impacts the long-term prognosis. A Mendelian inheritance pattern is observed in many diseases, underscoring the importance of a comprehensive examination of all babies with HSCR by a genetic counselor <xref ref-type="bibr" rid="scirp.139945-36">
     [36]
    </xref>.</p>
   <sec id="s5_1">
    <title>5.1. Genetic Conclusion</title>
    <p>In interrelationship marriages, individuals should be counseled on the features, impacts, and effects of their situation, including the genetic implications. HSCR is a congenital malformation with a 4% overall recurrence risk in the proband’s siblings (relative risk = 200). In isolated HSCR, the sex and aganglionic segment of the proband, as well as the gender of the sibling, provide adequate relative risk estimates. Many instances of HSCR are linked to other genetic abnormalities, and the severity of these associated malformations impacts the long-term prognosis. This highlights the significance of a genetic counselor’s comprehensive examination of all infants with HSCR <xref ref-type="bibr" rid="scirp.139945-37">
      [37]
     </xref>.</p>
   </sec>
   <sec id="s5_2">
    <title>5.2. Diagnosis</title>
    <p>Hirschsprung disease (HSCR) can be treated surgically by removing the colon segment lacking nerve cells. In contrast, Bardet-Biedl syndrome (BBS) has no definitive treatment and focuses on managing specific signs and symptoms. According to Bergmann <xref ref-type="bibr" rid="scirp.139945-38">
      [38]
     </xref>, BBS is associated with various classical features, and some patients may not receive a precise diagnosis for several years. Ogundele <xref ref-type="bibr" rid="scirp.139945-39">
      [39]
     </xref> noted that diagnosis difficulties often arise when a child has learning disabilities and weight management issues but no congenital abnormalities, making the diagnosis uncertain.</p>
    <p>Retinal disease diagnosis may require consultation with ophthalmologists and a definitive examination, such as an electroretinogram (ERG). Esposito <xref ref-type="bibr" rid="scirp.139945-40">
      [40]
     </xref> suggested that genetic testing could aid in diagnosing patients with BBS1 and BBS10 gene mutations, although Caudle et al. <xref ref-type="bibr" rid="scirp.139945-41">
      [41]
     </xref> pointed out that such tests may not be available in all laboratories. Primary treatment for BBS involves addressing specific symptoms, and kidney transplantation may be necessary for severe kidney disease <xref ref-type="bibr" rid="scirp.139945-38">
      [38]
     </xref>.</p>
    <p>Recent progress in HSCR stem cell-based medicinal research has been significant, though many essential questions remain unanswered. This review provides a brief background on HSCR, outlines future approaches to stem cell-based treatment, reviews key recent articles, and discusses ethical and technical challenges before clinical translation <xref ref-type="bibr" rid="scirp.139945-42">
      [42]
     </xref>.</p>
    <p>In HSCR, surgical treatment aims to restore normal bowel function and remove the tonic contraction of the internal anal sphincter <xref ref-type="bibr" rid="scirp.139945-43">
      [43]
     </xref>. Various surgical procedures, including the Soave and Duhamel procedures, are used. One-stage procedures are applicable for short-segment diseases, while long-segment diseases may require total colonic ganglions and temporary enterostomy before definitive surgery. Ghorbanpour et al. <xref ref-type="bibr" rid="scirp.139945-44">
      [44]
     </xref> proposed laparoscopic and transanal pull-through techniques for HSCR diagnosis. <xref ref-type="table" rid="table3">
      Table 3
     </xref> covers the complications and outcomes of HSCR Surgery.</p>
    <table-wrap id="table3">
     <label>
      <xref ref-type="table" rid="table3">
       Table 3
      </xref></label>
     <caption>
      <title>
       <xref ref-type="bibr" rid="scirp.139945-"></xref>Table 3. Complications and outcomes of HSCR surgery.</title>
     </caption>
     <table class="MsoTableGrid custom-table" border="0" cellspacing="0" cellpadding="0"> 
      <tr> 
       <td class="custom-bottom-td aleft" width="23.58%"><p style="text-align:left">Complication Type</p></td> 
       <td class="custom-bottom-td aleft" width="42.33%"><p style="text-align:left">Short-term Complications</p></td> 
       <td class="custom-bottom-td aleft" width="34.10%"><p style="text-align:left">Long-term Complications</p></td> 
      </tr> 
      <tr> 
       <td class="custom-top-td aleft" width="23.58%"><p style="text-align:left">Examples</p></td> 
       <td class="custom-top-td aleft" width="42.33%"><p style="text-align:left">Diarrhea, constipation, fever, rectal bleeding, fistula, enterocolitis</p></td> 
       <td class="custom-top-td aleft" width="34.10%"><p style="text-align:left">Chronic constipation, soiling</p></td> 
      </tr> 
      <tr> 
       <td class="aleft" width="23.58%"><p style="text-align:left">Mortality Rate</p></td> 
       <td class="aleft" width="42.33%"><p style="text-align:left">Less than 6% (mainly related to short-term complications and malformations)</p></td> 
       <td class="aleft" width="34.10%"><p style="text-align:left">-</p></td> 
      </tr> 
     </table>
    </table-wrap>
    <p>In the United States, approximately 90% of initial HSCR diagnoses occur within the first year of life, with 10% during childhood and less than 1% during adolescence or adulthood <xref ref-type="bibr" rid="scirp.139945-45">
      [45]
     </xref>. Postoperative treatment should include measures to minimize complications, such as regular physical examinations, kidney and urinary bladder function evaluations, and monitoring of vital signs. If all signs are normal, patients can be sent home with instructions for bowel irrigation three times a day at the operation site. Children with a history of HSCR are at higher risk of developing enterocolitis, characterized by explosive diarrhea, lethargy, and abdominal distension <xref ref-type="bibr" rid="scirp.139945-46">
      [46]
     </xref>.</p>
   </sec>
  </sec><sec id="s6">
   <title>6. Conclusion</title>
   <p>This review article explored the complex relationship between Hirschsprung’s disease (HSCR) and Bardet-Biedl syndrome (BBS), highlighting the genetic, developmental, and clinical aspects of these conditions. We examined the prevalence, pathogenesis, clinical presentation, and management of HSCR in children with BBS, drawing upon the latest research findings and clinical experience. Our findings highlight the complex interplay of genetic mutations, signaling pathways, and developmental processes involved in the pathogenesis of HSCR in BBS. Further research is needed to elucidate the precise mechanisms underlying this association and to develop targeted therapeutic strategies for children with HSCR and BBS.</p>
  </sec>
 </body><back>
  <ref-list>
   <title>References</title>
   <ref id="scirp.139945-ref1">
    <label>1</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Montalva, L., Cheng, L.S., Kapur, R., Langer, J.C., Berrebi, D., Kyrklund, K., et al. (2023) Hirschsprung Disease. Nature Reviews Disease Primers, 9, Article No. 54. &gt;https://doi.org/10.1038/s41572-023-00465-y 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref2">
    <label>2</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Butler Tjaden, N.E. and Trainor, P.A. (2013) The Developmental Etiology and Pathogenesis of Hirschsprung Disease. Translational Research, 162, 1-15. &gt;https://doi.org/10.1016/j.trsl.2013.03.001 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref3">
    <label>3</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Cherian, M.P., Al-Sanna’a, N.A. and Al-Mulhim, S.I. (2008) Hirschsprung’s Disease in Arab Siblings with Bardet-Biedl Syndrome. Journal of Pediatric Surgery, 43, 1213-1217. &gt;https://doi.org/10.1016/j.jpedsurg.2008.02.013 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref4">
    <label>4</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Forsythe, E. (2019) Understanding the Phenotype and Preparing for Therapeutics in Bardet-Biedl Syndrome. Doctoral Dissertation, University College London.
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref5">
    <label>5</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Day, M.L., Avila, C.C. and Novak, D.L. (2022) Hydrometrocolpos and Postaxial Polydactyly in a Girl Newborn: A Case Report. Clinical Case Reports, 10, e05453. &gt;https://doi.org/10.1002/ccr3.5453 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref6">
    <label>6</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Tao, T., Liu, J., Wang, B., Pang, J., Li, X. and Huang, L. (2022) Novel Mutations in BBS Genes and Clinical Characterization of Chinese Families with Bardet-Biedl Syndrome. European Journal of Ophthalmology, 33, 714-722. &gt;https://doi.org/10.1177/11206721221136324 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref7">
    <label>7</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Khan, S.A., Muhammad, N., Khan, M.A., Kamal, A., Rehman, Z.U. and Khan, S. (2016) Genetics of Human Bardet-Biedl Syndrome, an Updates. Clinical Genetics, 90, 3-15. &gt;https://doi.org/10.1111/cge.12737 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref8">
    <label>8</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Forsythe, E. and Beales, P.L. (2012) Bardet–Biedl Syndrome. European Journal of Human Genetics, 21, 8-13. &gt;https://doi.org/10.1038/ejhg.2012.115 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref9">
    <label>9</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     M’hamdi, O., Ouertani, I. and Chaabouni-Bouhamed, H. (2013) Update on the Genetics of Bardet-Biedl Syndrome. Molecular Syndromology, 5, 51-56. &gt;https://doi.org/10.1159/000357054 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref10">
    <label>10</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Martin, F.V., Valdez Jimenez, H.M., l Umaña Reye, M.E., Valadez García, V.M., Vargas Rivera, I.D. and Roselli Gutiérrez, E.M. (2023) Bardet-Biedl Syndrome: A Comprehensive Review of an Autosomal Recessive Ciliopathy. International Journal of Medical Science and Clinical Research Studies, 3, 2567-2571. &gt;https://doi.org/10.47191/ijmscrs/v3-i11-04 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref11">
    <label>11</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Blacque, O.E. and Leroux, M.R. (2006) Bardet-Biedl Syndrome: An Emerging Pathomechanism of Intracellular Transport. Cellular and Molecular Life Sciences, 63, 2145-2161. &gt;https://doi.org/10.1007/s00018-006-6180-x 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref12">
    <label>12</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Lee, H., Song, J., Jung, J.H. and Ko, H.W. (2015) Primary Cilia in Energy Balance Signaling and Metabolic Disorder. BMB Reports, 48, 647-654. &gt;https://doi.org/10.5483/bmbrep.2015.48.12.229 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref13">
    <label>13</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Mizock, B.A. (2009) The Multiple Organ Dysfunction Syndrome. Disease-a-Month, 55, 476-526. &gt;https://doi.org/10.1016/j.disamonth.2009.04.002 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref14">
    <label>14</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Billingsley, G., Deveault, C. and Héon, E. (2011) BBS Mutational Analysis: A Strategic Approach. Ophthalmic Genetics, 32, 181-187. &gt;https://doi.org/10.3109/13816810.2011.567319 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref15">
    <label>15</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Ece Solmaz, A., Onay, H., Atik, T., Aykut, A., Cerrah Gunes, M., Ozalp Yuregir, O., et al. (2015) Targeted Multi-Gene Panel Testing for the Diagnosis of Bardet Biedl Syndrome: Identification of Nine Novel Mutations across BBS1, BBS2, BBS4, BBS7, BBS9, BBS10 Genes. European Journal of Medical Genetics, 58, 689-694. &gt;https://doi.org/10.1016/j.ejmg.2015.10.011 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref16">
    <label>16</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Shevach, E., Ali, M., Mizrahi-Meissonnier, L., McKibbin, M., El-Asrag, M., Watson, C.M., et al. (2015) Association between Missense Mutations in the BBS2 Gene and Nonsyndromic Retinitis Pigmentosa. JAMA Ophthalmology, 133, 312-318. &gt;https://doi.org/10.1001/jamaophthalmol.2014.5251 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref17">
    <label>17</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Zhao, Y. and Rahmouni, K. (2022) Bbsome: A New Player in Hypertension and Other Cardiovascular Risks. Hypertension, 79, 303-313. &gt;https://doi.org/10.1161/hypertensionaha.121.17946 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref18">
    <label>18</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Zelihić, D., Hjardemaal, F.R. and Lippe, C.v.d. (2020) Caring for a Child with Bardet-Biedl Syndrome: A Qualitative Study of the Parental Experiences of Daily Coping and Support. European Journal of Medical Genetics, 63, Article 103856. &gt;https://doi.org/10.1016/j.ejmg.2020.103856 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref19">
    <label>19</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Al-Mat’hammi, A.A., Alzahrani, S.A., Alsefry, F.S., Ghurab, S. and Alghamdi, M. (2024) Homozygous Pathogenic Variant in BBS9 Gene: A Detailed Case Study of Bardet-Biedl Syndrome. Cureus, 16, e65774. &gt;https://doi.org/10.7759/cureus.65774 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref20">
    <label>20</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Azari, A.A., Aleman, T.S., Cideciyan, A.V., Schwartz, S.B., Windsor, E.A.M., Sumaroka, A., et al. (2006) Retinal Disease Expression in Bardet-Biedl Syndrome-1 (BBS1) Is a Spectrum from Maculopathy to Retina-Wide Degeneration. Investigative Opthalmology&amp;Visual Science, 47, 5004-5010. &gt;https://doi.org/10.1167/iovs.06-0517 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref21">
    <label>21</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Beales, P.L., Elcioglu, N., Woolf, A.S., Parker, D. and Flinter, F.A. (1999) New Criteria for Improved Diagnosis of Bardet-Biedl Syndrome: Results of a Population Survey. Journal of Medical Genetics, 36, 437-446. &gt;https://doi.org/10.1136/jmg.36.6.437 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref22">
    <label>22</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Caba, L., Florea, L., Braha, E.E., Lupu, V.V. and Gorduza, E.V. (2022) Monitoring and Management of Bardet-Biedl Syndrome: What the Multi-Disciplinary Team Can Do. Journal of Multidisciplinary Healthcare, 15, 2153-2167. &gt;https://doi.org/10.2147/jmdh.s274739 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref23">
    <label>23</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Dollfus, H., Lilien, M.R., Maffei, P., Verloes, A., Muller, J., Bacci, G.M., et al. (2024) Bardet-Biedl Syndrome Improved Diagnosis Criteria and Management: Inter European Reference Networks Consensus Statement and Recommendations. European Journal of Human Genetics, 32, 1347-1360. &gt;https://doi.org/10.1038/s41431-024-01634-7 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref24">
    <label>24</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Priya, S., Nampoothiri, S., Sen, P. and Sripriya, S. (2016) Bardet–Biedl Syndrome: Genetics, Molecular Pathophysiology, and Disease Management. Indian Journal of Ophthalmology, 64, 620-627. &gt;https://doi.org/10.4103/0301-4738.194328 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref25">
    <label>25</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Shikwambana, M.M. and Fourie, J.V. (2023) Supporting a Tsonga Learner Living with Bardet-Biedl Syndrome, a Rare Complex Disability. African Journal of Disability, 12, Article 1181. &gt;https://doi.org/10.4102/ajod.v12i0.1181 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref26">
    <label>26</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Eshel Fuhrer, A., Govorukhina, O., Becker, G., Ben-Shahar, Y., Moran-Lev, H. and Sukhotnik, I. (2024) Extended Total Colonic Aganglionosis and Total Intestinal Aganglionosis: Challenging Enemies. Acta Paediatrica, 113, 2297-2303. &gt;https://doi.org/10.1111/apa.17341 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref27">
    <label>27</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Owens, E. (2022) The Qualitative and Quantitative Outcomes of Children with Hirschsprung’s Disease and Anorectal Malformations. Doctoral Dissertation, The University of Liverpool.
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref28">
    <label>28</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Karim, A., Tang, C.S. and Tam, P.K. (2021) The Emerging Genetic Landscape of Hirschsprung Disease and Its Potential Clinical Applications. Frontiers in Pediatrics, 9, Article 638093. &gt;https://doi.org/10.3389/fped.2021.638093 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref29">
    <label>29</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Munnes, M., Fanaei, S., Schmitz, B., Muiznieks, I., Holschneider, A.M. and Doerfler, W. (2000) Familial Form of Hirschsprung Disease: Nucleotide Sequence Studies Reveal Point Mutations in the RET Proto-Oncogene in Two of Six Families but Not in Other Candidate Genes. American Journal of Medical Genetics, 94, 19-27. &gt;https://doi.org/10.1002/1096-8628(20000904)94:1&lt;19::aid-ajmg5&gt;3.0.co;2-k 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref30">
    <label>30</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Zhang, Y., He, Q., Zhang, R., Zhang, H., Zhong, W. and Xia, H. (2017) Large-Scale Replication Study Identified Multiple Independent SNPs in RET Synergistically Associated with Hirschsprung Disease in Southern Chinese Population. Aging, 9, 1996-2009. &gt;https://doi.org/10.18632/aging.101294 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref31">
    <label>31</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Chauhan, R. (2016) Genetic and Functional Studies of Hirschsprung Disease. Doctoral Thesis, Erasmus University Rotterdam.
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref32">
    <label>32</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Kuil, L.E., MacKenzie, K.C., Tang, C.S., Windster, J.D., Le, T.L., Karim, A., de Graaf, B.M., van der Helm, R., van Bever, Y., Sloots, C.E. and Meeussen, C. (2021) Size Matters: Large Copy Number Losses in Hirschsprung Disease Patients Reveal Genes Involved in Enteric Nervous System Development. PLOS Genetics, 17, e1009698.
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref33">
    <label>33</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Kapur, R.P., Smith, C. and Ambartsumyan, L. (2019) Postoperative Pullthrough Obstruction in Hirschsprung Disease: Etiologies and Diagnosis. Pediatric and Developmental Pathology, 23, 40-59. &gt;https://doi.org/10.1177/1093526619890735 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref34">
    <label>34</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Maria, M., Lamers, I.J., Schmidts, M., Ajmal, M., Jaffar, S., et al. (2012) Pharmacological Modulation of the Retinal Unfolded Protein Response in Bardet-Biedl Syndrome Reduces Apoptosis and Preserves Light Detection Ability. Journal of Biological Chemistry, 287, 37483-37494. 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref35">
    <label>35</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Barnett, S. (2002) Behavioural Phenotype of Bardet-Biedl Syndrome. Journal of Medical Genetics, 39, 76e-76. &gt;https://doi.org/10.1136/jmg.39.12.e76 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref36">
    <label>36</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Tang, C.S., Karim, A., Zhong, Y., Chung, P.H. and Tam, P.K. (2023) Genetics of Hirschsprung’s Disease. Pediatric Surgery International, 39, Article No. 104. &gt;https://doi.org/10.1007/s00383-022-05358-x 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref37">
    <label>37</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Emison, E.S., Garcia-Barcelo, M., Grice, E.A., Lantieri, F., Amiel, J., Burzynski, G., et al. (2010) Differential Contributions of Rare and Common, Coding and Noncoding Ret Mutations to Multifactorial Hirschsprung Disease Liability. The American Journal of Human Genetics, 87, 60-74. &gt;https://doi.org/10.1016/j.ajhg.2010.06.007 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref38">
    <label>38</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Bergmann, C. (2018) Genetics of Autosomal Recessive Polycystic Kidney Disease and Its Differential Diagnoses. Frontiers in Pediatrics, 5, Article 221. &gt;https://doi.org/10.3389/fped.2017.00221 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref39">
    <label>39</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Ogundele, M.O. (2018) Behavioural and Emotional Disorders in Childhood: A Brief Overview for Paediatricians. World Journal of Clinical Pediatrics, 7, 9-26. &gt;https://doi.org/10.5409/wjcp.v7.i1.9 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref40">
    <label>40</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Esposito, G., Testa, F., Zacchia, M., Crispo, A.A., Di Iorio, V., Capolongo, G., et al. (2017) Genetic Characterization of Italian Patients with Bardet-Biedl Syndrome and Correlation to Ocular, Renal and Audio-Vestibular Phenotype: Identification of Eleven Novel Pathogenic Sequence Variants. BMC Medical Genetics, 18, Article No. 10. &gt;https://doi.org/10.1186/s12881-017-0372-0 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref41">
    <label>41</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Caudle, K.E., Dunnenberger, H.M., Freimuth, R.R., Peterson, J.F., Burlison, J.D., Whirl-Carrillo, M., et al. (2017) Standardizing Terms for Clinical Pharmacogenetic Test Results: Consensus Terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC). Genetics in Medicine, 19, 215-223. &gt;https://doi.org/10.1038/gim.2016.87 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref42">
    <label>42</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Alhawaj, A.F. (2021) Stem Cell-Based Therapy for Hirschsprung Disease, Do We Have the Guts to Treat? Gene Therapy, 29, 578-587. &gt;https://doi.org/10.1038/s41434-021-00268-4 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref43">
    <label>43</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Huang, W., Li, X., Zhang, J. and Zhang, S. (2018) Prevalence, Risk Factors, and Prognosis of Postoperative Complications after Surgery for Hirschsprung Disease. Journal of Gastrointestinal Surgery, 22, 335-343. &gt;https://doi.org/10.1007/s11605-017-3596-6 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref44">
    <label>44</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Ghorbanpour, M., Seyfrabie, M.A. and Yousefi, B. (2019) Early and Long-Term Complications Following Transanal Pull through Soave Technique in Infants with Hirschsprung’s Diseaseric Infants with Hirschsprung’s Disease. Medicine and Pharmacy Reports, 92, 382-386. &gt;https://doi.org/10.15386/mpr-1314 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref45">
    <label>45</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Pruitt, L.C.C., Skarda, D.E., Rollins, M.D. and Bucher, B.T. (2020) Hirschsprung-Associated Enterocolitis in Children Treated at US Children’s Hospitals. Journal of Pediatric Surgery, 55, 535-540. &gt;https://doi.org/10.1016/j.jpedsurg.2019.10.060 
    </mixed-citation>
   </ref>
   <ref id="scirp.139945-ref46">
    <label>46</label>
    <mixed-citation publication-type="other" xlink:type="simple">
     Gershon, E.M., Rodriguez, L. and Arbizu, R.A. (2023) Hirschsprung’s Disease Associated Enterocolitis: A Comprehensive Review. World Journal of Clinical Pediatrics, 12, 68-76. &gt;https://doi.org/10.5409/wjcp.v12.i3.68
    </mixed-citation>
   </ref>
  </ref-list>
 </back>
</article>